» Articles » PMID: 27866203

Frontal Assessment Battery As a Useful Tool to Differentiate Mild Cognitive Impairment Due to Subcortical Ischemic Vascular Disease from Alzheimer Disease

Overview
Publisher Karger
Date 2016 Nov 21
PMID 27866203
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prominent executive dysfunction can differentiate vascular dementia from Alzheimer disease (AD). However, it is unclear whether the Frontal Assessment Battery (FAB) screening tool can differentiate subcortical ischemic vascular disease (SIVD) from AD at the pre-dementia stage. In addition, the neural correlates of FAB performance have yet to be clarified.

Methods: Patients with mild cognitive impairment (MCI) due to SIVD (MCI-V), MCI due to AD (MCI-A), and demographically matched controls completed the Mini-Mental State Examination, Taiwanese FAB (TFAB), Category Fluency, and Chinese Version of the Verbal Learning Test, and underwent magnetic resonance imaging. White matter hyperintensities were rated according to the Scheltens scale.

Results: TFAB total scale and its Orthographical Fluency subtest were the only measures that could differentiate MCI-V from MCI-A. Discriminative analysis showed that Orthographical Fluency scores successfully identified 73.2% of the cases with MCI-V, with 85.0% sensitivity. Orthographical Fluency scores were specifically associated with lesion load within frontal periventricular, frontal deep white matter, and basal ganglia regions.

Conclusion: The TFAB, and especially its 1-min Orthographical Fluency subtest, is a useful screening procedure to differentiate MCI due to SIVD from MCI due to AD. The discriminative ability is probably due to frontosubcortical white matter pathologies disproportionately involved in the two disease entities.

Citing Articles

Neurovascular Correlates of Cobalamin, Folate, and Homocysteine in Dementia.

Tu M, Chung H, Hsu Y, Yang J, Wu W J Alzheimers Dis. 2023; 96(3):1329-1338.

PMID: 37980672 PMC: 10741318. DOI: 10.3233/JAD-230763.


Diagnosis of Subcortical Ischemic Vascular Cognitive Impairment With No Dementia Using Radiomics of Cerebral Cortex and Subcortical Nuclei in High-Resolution T1-Weighted MR Imaging.

Liu B, Meng S, Cheng J, Zeng Y, Zhou D, Deng X Front Oncol. 2022; 12:852726.

PMID: 35463351 PMC: 9027106. DOI: 10.3389/fonc.2022.852726.


The clinical profile of cerebral small vessel disease: Toward an evidence-based identification of cognitive markers.

Salvadori E, Brambilla M, Maestri G, Nicotra A, Cova I, Pomati S Alzheimers Dement. 2022; 19(1):244-260.

PMID: 35362229 PMC: 10084195. DOI: 10.1002/alz.12650.


Sex Differences in Cerebral Small Vessel Disease: A Systematic Review and Meta-Analysis.

Jimenez-Sanchez L, Hamilton O, Clancy U, Backhouse E, Stewart C, Stringer M Front Neurol. 2021; 12:756887.

PMID: 34777227 PMC: 8581736. DOI: 10.3389/fneur.2021.756887.


Exosomal MicroRNAs Contribute to Cognitive Impairment in Hypertensive Patients by Decreasing Frontal Cerebrovascular Reactivity.

Ma J, Cao X, Chen F, Ye Q, Qin R, Cheng Y Front Neurosci. 2021; 15:614220.

PMID: 33732103 PMC: 7957933. DOI: 10.3389/fnins.2021.614220.